Inova Labs

Inova Labs markets portable oxygen concentrators for patients suffering from respiratory conditions such as chronic obstructive pulmonary disease (COPD).

After Gilde invested in Inova Labs, the company built up an international marketing and sales organization, received clearance by the US Food and Drug Administration for its lead product LifeChoice® Activox, and launched the product in Asia, Europe and Latin America.

There are 13 million people diagnosed with COPD in the United States alone. Portable oxygen concentrators like the LifeChoice® Activox can give patients their freedom back to engage in regular daily activities.

Inova Labs is based in Austin, Texas.